STOKNasdaq United States
Market cap
$2.111 B
$32.71 +2.44%
Close of 7 Aug 2026
Revenue
$184.4M
#2322 by revenue
Earnings
-$6.88M
Loss-making
Shares outstanding
64,526,242
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Stoke Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.